AFL
AFLAC INC
Company overview
- Market capitalization
- $56.93B
- Employees
- 12,716
- Latest publication
- 2026-09-29
About AFLAC INC
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
Financial statements
Income YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Total Revenue | 8,463,000,000USD |
| Interest Expense | 124,000,000USD |
| Income Before Tax | 2,220,000,000USD |
| Income Tax Expense | 376,000,000USD |
| Net Income | 1,844,000,000USD |
| Source | DisclosureDeterministicFinal |
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,117,000,000USD | 4,315,000,000USD | 4,896,000,000USD | 4,793,000,000USD | 4,218,000,000USD | 3,453,000,000USD | 5,498,000,000USD | 3,035,000,000USD |
| Interest Expense | 64,000,000USD | 60,000,000USD | 61,000,000USD | 57,000,000USD | 52,000,000USD | 50,000,000USD | 50,000,000USD | 50,000,000USD |
| Income Before Tax | 995,000,000USD | 1,225,000,000USD | 1,572,000,000USD | 1,994,000,000USD | 822,000,000USD | 145,000,000USD | 2,135,000,000USD | 92,000,000USD |
| Income Tax Expense | 170,000,000USD | 206,000,000USD | 193,000,000USD | 355,000,000USD | 223,000,000USD | 116,000,000USD | 233,000,000USD | 185,000,000USD |
| Net Income | 825,000,000USD | 1,019,000,000USD | 1,379,000,000USD | 1,639,000,000USD | 599,000,000USD | 29,000,000USD | 1,902,000,000USD | -93,000,000USD |
| Cost Of Revenue | — | 1,832,000,000USD | 1,963,000,000USD | 2,689,000,000USD | 3,035,000,000USD | 2,963,000,000USD | 2,971,000,000USD | 2,556,000,000USD |
| Gross Profit | — | 2,483,000,000USD | 2,933,000,000USD | 2,104,000,000USD | 1,183,000,000USD | 490,000,000USD | 2,527,000,000USD | 479,000,000USD |
| Unclassified Operating Expenses | — | 1,258,000,000USD | 219,000,000USD | -671,000,000USD | -443,000,000USD | -457,000,000USD | -219,000,000USD | -360,000,000USD |
| Total Operating Expenses | — | 1,258,000,000USD | 1,331,000,000USD | 110,000,000USD | 361,000,000USD | 345,000,000USD | 392,000,000USD | 387,000,000USD |
| Operating Income | — | 1,225,000,000USD | 1,602,000,000USD | 1,994,000,000USD | 822,000,000USD | 145,000,000USD | 2,135,000,000USD | 92,000,000USD |
| Net Interest Income | — | -60,000,000USD | -61,000,000USD | -57,000,000USD | -52,000,000USD | -50,000,000USD | -50,000,000USD | -50,000,000USD |
| Tax Provision | — | 206,000,000USD | 193,000,000USD | 355,000,000USD | 223,000,000USD | 116,000,000USD | 233,000,000USD | 185,000,000USD |
| Net Income From Continuing Ops | — | 1,019,000,000USD | 1,379,000,000USD | 1,639,000,000USD | 599,000,000USD | 29,000,000USD | 1,902,000,000USD | -93,000,000USD |
| Ebitda | — | 1,285,000,000USD | 1,852,000,000USD | 2,706,000,000USD | 822,000,000USD | 145,000,000USD | 2,135,000,000USD | 92,000,000USD |
| Total Other Income Expense Net | — | 31,000,000USD | -30,000,000USD | 26,000,000USD | -52,000,000USD | 25,000,000USD | 2,135,000,000USD | -1,595,000,000USD |
| Selling General Administrative | — | — | 866,000,000USD | 781,000,000USD | 804,000,000USD | 802,000,000USD | 611,000,000USD | 747,000,000USD |
| Selling And Marketing Expenses | — | — | 246,000,000USD | — | — | — | — | — |
| Interest Income | — | — | 61,000,000USD | 57,000,000USD | 52,000,000USD | 50,000,000USD | 50,000,000USD | 50,000,000USD |
| Ebit | — | — | 1,602,000,000USD | 2,051,000,000USD | 822,000,000USD | 145,000,000USD | 2,135,000,000USD | 92,000,000USD |
| Depreciation And Amortization | — | — | 250,000,000USD | 655,000,000USD | — | — | — | — |
| Net Income Applicable To Common Shares | — | — | 1,379,000,000USD | 1,639,000,000USD | 599,000,000USD | 29,000,000USD | 1,902,000,000USD | -93,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 17,438,000,000USD | 19,128,000,000USD | 18,841,000,000USD | 19,151,000,000USD | 22,106,000,000USD | 22,147,000,000USD | 22,307,000,000USD | 21,758,000,000USD |
| Cost Of Revenue | 10,650,000,000USD | 12,313,000,000USD | — | 275,000,000USD | — | — | 14,545,000,000USD | 14,565,000,000USD |
| Gross Profit | 6,788,000,000USD | 6,815,000,000USD | 18,841,000,000USD | 19,151,000,000USD | 22,106,000,000USD | 22,147,000,000USD | 22,307,000,000USD | 21,758,000,000USD |
| Selling General Administrative | 2,451,000,000USD | 2,790,000,000USD | 2,928,000,000USD | 2,994,000,000USD | 287,000,000USD | 240,000,000USD | 273,000,000USD | 291,000,000USD |
| Unclassified Operating Expenses | -304,000,000USD | -2,392,000,000USD | 10,463,000,000USD | 11,084,000,000USD | -17,071,000,000USD | -18,228,000,000USD | -18,135,000,000USD | -17,844,000,000USD |
| Total Operating Expenses | 2,147,000,000USD | 398,000,000USD | 13,579,000,000USD | 14,282,000,000USD | -16,784,000,000USD | -17,988,000,000USD | -17,862,000,000USD | -17,553,000,000USD |
| Operating Income | 4,641,000,000USD | 6,417,000,000USD | 5,262,000,000USD | 4,869,000,000USD | 5,322,000,000USD | 4,159,000,000USD | 4,445,000,000USD | 4,205,000,000USD |
| Interest Income | 220,000,000USD | 197,000,000USD | 195,000,000USD | 226,000,000USD | 238,000,000USD | 242,000,000USD | 228,000,000USD | 222,000,000USD |
| Interest Expense | 220,000,000USD | 197,000,000USD | 195,000,000USD | 226,000,000USD | 238,000,000USD | 242,000,000USD | 228,000,000USD | 222,000,000USD |
| Net Interest Income | -220,000,000USD | -197,000,000USD | -203,000,000USD | -226,000,000USD | -238,000,000USD | -242,000,000USD | -228,000,000USD | -222,000,000USD |
| Income Before Tax | 4,533,000,000USD | 6,417,000,000USD | 5,262,000,000USD | 4,869,000,000USD | 5,322,000,000USD | 4,159,000,000USD | 4,445,000,000USD | 3,983,000,000USD |
| Income Tax Expense | 887,000,000USD | 974,000,000USD | 603,000,000USD | 451,000,000USD | 997,000,000USD | -619,000,000USD | 1,141,000,000USD | 1,063,000,000USD |
| Tax Provision | 887,000,000USD | 974,000,000USD | 875,000,000USD | 403,000,000USD | 997,000,000USD | -619,000,000USD | 1,141,000,000USD | 1,063,000,000USD |
| Net Income | 3,646,000,000USD | 5,443,000,000USD | 4,659,000,000USD | 4,418,000,000USD | 4,325,000,000USD | 4,778,000,000USD | 3,304,000,000USD | 2,920,000,000USD |
| Net Income From Continuing Ops | 3,646,000,000USD | 5,443,000,000USD | 4,370,000,000USD | 4,201,000,000USD | 4,325,000,000USD | 4,778,000,000USD | 3,304,000,000USD | 2,920,000,000USD |
| Ebit | 4,651,000,000USD | 6,417,000,000USD | 5,457,000,000USD | 5,095,000,000USD | 5,322,000,000USD | 4,159,000,000USD | 4,445,000,000USD | 4,205,000,000USD |
| Ebitda | 5,525,000,000USD | 6,417,000,000USD | 5,262,000,000USD | 4,869,000,000USD | 6,492,000,000USD | 5,373,000,000USD | 4,445,000,000USD | 4,205,000,000USD |
| Depreciation And Amortization | 874,000,000USD | — | 39,000,000USD | 45,000,000USD | 1,170,000,000USD | 1,214,000,000USD | 41,000,000USD | — |
| Total Other Income Expense Net | -108,000,000USD | 6,190,000,000USD | -10,274,000,000USD | -11,022,000,000USD | -238,000,000USD | -242,000,000USD | -228,000,000USD | -222,000,000USD |
| Net Income Applicable To Common Shares | 3,646,000,000USD | 5,443,000,000USD | 4,659,000,000USD | 4,201,000,000USD | 4,325,000,000USD | 4,778,000,000USD | 3,304,000,000USD | 2,920,000,000USD |
| Selling And Marketing Expenses | — | — | 188,000,000USD | 204,000,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 115,961,000,000USD | 116,280,000,000USD | 116,470,000,000USD | 122,134,000,000USD | 124,736,000,000USD | 120,258,000,000USD | 117,566,000,000USD | 128,442,000,000USD |
| Cash And Equivalents | 6,120,000,000USD | — | 6,245,000,000USD | 6,768,000,000USD | 6,965,000,000USD | 5,231,000,000USD | 6,229,000,000USD | 5,612,000,000USD |
| Total Liabilities | 85,649,000,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 30,312,000,000USD | 29,961,000,000USD | 29,490,000,000USD | 28,688,000,000USD | 27,200,000,000USD | 26,338,000,000USD | 26,098,000,000USD | 24,830,000,000USD |
| Property Plant Equipment Net | 351,000,000USD | 1,207,000,000USD | 351,000,000USD | 1,307,000,000USD | 390,000,000USD | 391,000,000USD | 387,000,000USD | 421,000,000USD |
| Common Stock | 136,000,000USD | 136,000,000USD | 136,000,000USD | 136,000,000USD | 136,000,000USD | 136,000,000USD | 136,000,000USD | 136,000,000USD |
| Retained Earnings | 56,218,000,000USD | 55,702,000,000USD | 54,682,000,000USD | 53,923,000,000USD | 52,595,000,000USD | 52,308,000,000USD | 52,277,000,000USD | 50,972,000,000USD |
| Intangible Assets | — | 8,976,000,000USD | 9,034,000,000USD | 9,216,000,000USD | 9,296,000,000USD | 9,083,000,000USD | 8,758,000,000USD | 9,232,000,000USD |
| Total Liab | — | 86,319,000,000USD | 86,980,000,000USD | 93,446,000,000USD | 97,536,000,000USD | 93,920,000,000USD | 91,468,000,000USD | 103,612,000,000USD |
| Other Current Liab | — | 6,936,000,000USD | 3,116,000,000USD | -1,876,000,000USD | -771,000,000USD | -815,000,000USD | -573,000,000USD | -454,000,000USD |
| Capital Stock | — | 136,000,000USD | 136,000,000USD | 136,000,000USD | 136,000,000USD | 136,000,000USD | 136,000,000USD | 136,000,000USD |
| Cash | — | 5,654,000,000USD | 6,245,000,000USD | 6,768,000,000USD | 6,965,000,000USD | 5,231,000,000USD | 6,229,000,000USD | 5,612,000,000USD |
| Cash And Short Term Investments | — | 71,498,000,000USD | 70,398,000,000USD | 76,424,000,000USD | 75,879,000,000USD | 72,408,000,000USD | 71,498,000,000USD | 10,671,000,000USD |
| Total Current Assets | — | 73,140,000,000USD | 71,951,000,000USD | 71,204,000,000USD | 73,042,000,000USD | 73,302,000,000USD | 4,021,000,000USD | 74,687,000,000USD |
| Total Current Liabilities | — | 8,254,000,000USD | 5,807,000,000USD | 1,477,000,000USD | 685,000,000USD | 815,000,000USD | — | 454,000,000USD |
| Current Deferred Revenue | — | 1,318,000,000USD | 1,323,000,000USD | — | — | — | — | — |
| Net Debt | — | 2,254,000,000USD | 2,164,000,000USD | 2,000,000,000USD | 1,968,000,000USD | 2,520,000,000USD | 1,269,000,000USD | 2,366,000,000USD |
| Short Long Term Debt Total | — | 7,908,000,000USD | 8,409,000,000USD | 8,768,000,000USD | 8,933,000,000USD | 7,751,000,000USD | 7,498,000,000USD | 7,978,000,000USD |
| Long Term Debt | — | 7,822,000,000USD | 8,409,000,000USD | 8,598,000,000USD | 8,751,000,000USD | 7,653,000,000USD | 7,402,000,000USD | 7,868,000,000USD |
| Long Term Investments | — | 86,673,000,000USD | 81,128,000,000USD | 91,423,000,000USD | 87,195,000,000USD | 84,796,000,000USD | 82,031,000,000USD | 90,798,000,000USD |
| Short Term Investments | — | 65,844,000,000USD | 64,153,000,000USD | 69,656,000,000USD | 68,914,000,000USD | 67,177,000,000USD | 65,269,000,000USD | 5,059,000,000USD |
| Net Receivables | — | 1,642,000,000USD | 1,553,000,000USD | 852,000,000USD | 873,000,000USD | 894,000,000USD | 779,000,000USD | 814,000,000USD |
| Accumulated Other Comprehensive Income | — | 1,901,000,000USD | 1,452,000,000USD | 653,000,000USD | -491,000,000USD | -1,859,000,000USD | -2,978,000,000USD | -3,677,000,000USD |
| Common Stock Shares Outstanding | — | 514,784,999shares | 532,015,000shares | 532,015,000shares | 538,425,000shares | 546,878,000shares | 565,015,000shares | 560,414,000shares |
| Non Current Assets Total | — | 43,140,000,000USD | 44,519,000,000USD | 367,000,000USD | 390,000,000USD | 391,000,000USD | 30,563,000,000USD | 421,000,000USD |
| Non Current Liabilities Total | — | 78,065,000,000USD | 81,173,000,000USD | 93,618,000,000USD | 97,536,000,000USD | 93,920,000,000USD | 91,468,000,000USD | 87,100,000,000USD |
| Non Currrent Assets Other | — | 2,116,000,000USD | 1,772,000,000USD | -101,946,000,000USD | -96,881,000,000USD | -85,187,000,000USD | -82,418,000,000USD | -91,219,000,000USD |
| Unclassified Non Current Assets | — | -55,832,000,000USD | -48,026,000,000USD | -223,885,000,000USD | -221,227,000,000USD | -214,137,000,000USD | -178,442,000,000USD | -228,472,000,000USD |
| Unclassified Non Current Liabilities | — | 70,243,000,000USD | 72,764,000,000USD | 85,020,000,000USD | 88,785,000,000USD | 86,267,000,000USD | 84,066,000,000USD | 79,232,000,000USD |
| Unclassified Equity | — | -27,914,000,000USD | -26,916,000,000USD | -26,160,000,000USD | -25,176,000,000USD | -24,383,000,000USD | -23,473,000,000USD | -22,737,000,000USD |
| Other Current Assets | — | — | 718,000,000USD | -77,276,000,000USD | -76,752,000,000USD | -73,302,000,000USD | -72,277,000,000USD | -11,485,000,000USD |
| Good Will | — | — | 260,000,000USD | — | — | — | 263,000,000USD | — |
| Short Term Debt | — | — | 0USD | 399,000,000USD | 86,000,000USD | 0USD | 124,000,000USD | 87,000,000USD |
| Unclassified Current Liabilities | — | — | 1,368,000,000USD | 1,078,000,000USD | 513,000,000USD | 815,000,000USD | — | 367,000,000USD |
| Other Assets | — | — | — | 122,306,000,000USD | 124,736,000,000USD | 120,258,000,000USD | 117,566,000,000USD | 128,442,000,000USD |
| Short Long Term Debt | — | — | — | 0USD | 86,000,000USD | — | — | — |
| Unclassified Current Assets | — | — | — | -6,072,000,000USD | -3,710,000,000USD | — | -68,256,000,000USD | 63,202,000,000USD |
| Inventory | — | — | — | — | — | — | — | -8,451,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 116,470,000,000USD | 117,566,000,000USD | 126,724,000,000USD | 131,738,000,000USD | 157,542,000,000USD | 165,086,000,000USD | 152,768,000,000USD | 140,406,000,000USD |
| Intangible Assets | 9,034,000,000USD | 8,758,000,000USD | 9,132,000,000USD | 8,593,000,000USD | 9,525,000,000USD | 10,441,000,000USD | 10,128,000,000USD | 9,875,000,000USD |
| Other Current Assets | 718,000,000USD | -72,277,000,000USD | -78,444,000,000USD | 7,229,000,000USD | 43,721,000,000USD | 7,842,000,000USD | 7,378,000,000USD | -851,000,000USD |
| Total Liab | 86,980,000,000USD | 91,468,000,000USD | 104,739,000,000USD | 111,598,000,000USD | 124,289,000,000USD | 7,899,000,000USD | 123,809,000,000USD | 116,944,000,000USD |
| Total Stockholder Equity | 29,490,000,000USD | 26,098,000,000USD | 21,985,000,000USD | 20,140,000,000USD | 33,253,000,000USD | 157,187,000,000USD | 28,959,000,000USD | 23,462,000,000USD |
| Other Current Liab | 3,116,000,000USD | -573,000,000USD | -577,000,000USD | 1,241,000,000USD | 4,339,000,000USD | 4,605,000,000USD | -5,370,000,000USD | 111,179,000,000USD |
| Common Stock | 136,000,000USD | 136,000,000USD | 136,000,000USD | 135,000,000USD | 135,000,000USD | 135,000,000USD | 135,000,000USD | 135,000,000USD |
| Capital Stock | 136,000,000USD | 136,000,000USD | 136,000,000USD | 135,000,000USD | 135,000,000USD | 135,000,000USD | 135,000,000USD | 135,000,000USD |
| Retained Earnings | 54,682,000,000USD | 52,277,000,000USD | 47,993,000,000USD | 44,367,000,000USD | 41,381,000,000USD | 37,984,000,000USD | 34,291,000,000USD | 31,788,000,000USD |
| Good Will | 260,000,000USD | 263,000,000USD | 265,000,000USD | 265,000,000USD | 268,000,000USD | 269,000,000USD | — | — |
| Cash | 6,245,000,000USD | 6,229,000,000USD | 4,306,000,000USD | 3,943,000,000USD | 5,051,000,000USD | 5,141,000,000USD | 4,896,000,000USD | 4,337,000,000USD |
| Cash And Equivalents | 6,245,000,000USD | 6,229,000,000USD | 4,306,000,000USD | 3,943,000,000USD | 5,051,000,000USD | 5,141,000,000USD | 4,896,000,000USD | 4,337,000,000USD |
| Cash And Short Term Investments | 70,398,000,000USD | 71,498,000,000USD | 77,596,000,000USD | 79,684,000,000USD | 103,747,000,000USD | 111,023,000,000USD | 96,158,000,000USD | 87,232,000,000USD |
| Total Current Assets | 71,951,000,000USD | 4,021,000,000USD | 29,071,000,000USD | 80,331,000,000USD | 143,671,000,000USD | 111,819,000,000USD | 96,986,000,000USD | 88,083,000,000USD |
| Total Current Liabilities | 5,807,000,000USD | 573,000,000USD | 2,210,000,000USD | 1,296,000,000USD | 7,956,000,000USD | 4,661,000,000USD | 5,370,000,000USD | 4,020,000,000USD |
| Current Deferred Revenue | 1,323,000,000USD | — | — | — | — | — | — | — |
| Net Debt | 2,164,000,000USD | 1,269,000,000USD | 3,058,000,000USD | 3,499,000,000USD | 2,905,000,000USD | 2,758,000,000USD | 1,673,000,000USD | 1,441,000,000USD |
| Short Term Debt | 0USD | 124,000,000USD | 52,000,000USD | 55,000,000USD | 7,956,000,000USD | 56,000,000USD | 53,000,000USD | 5,778,000,000USD |
| Short Long Term Debt Total | 8,409,000,000USD | 7,498,000,000USD | 7,364,000,000USD | 7,497,000,000USD | 15,807,000,000USD | 7,955,000,000USD | 6,569,000,000USD | 5,778,000,000USD |
| Long Term Debt | 8,409,000,000USD | 7,402,000,000USD | 7,240,000,000USD | 7,442,000,000USD | 7,839,000,000USD | 7,899,000,000USD | 6,408,000,000USD | 5,765,000,000USD |
| Long Term Investments | 81,128,000,000USD | 82,031,000,000USD | 92,197,000,000USD | 80,556,000,000USD | 115,061,000,000USD | 144,119,000,000USD | 772,000,000USD | 773,000,000USD |
| Short Term Investments | 64,153,000,000USD | 65,269,000,000USD | 73,290,000,000USD | 75,741,000,000USD | 98,696,000,000USD | 105,882,000,000USD | 91,262,000,000USD | 82,895,000,000USD |
| Net Receivables | 1,553,000,000USD | 779,000,000USD | 848,000,000USD | 647,000,000USD | 693,000,000USD | 796,000,000USD | 828,000,000USD | 851,000,000USD |
| Property Plant Equipment Net | 351,000,000USD | 387,000,000USD | 445,000,000USD | 530,000,000USD | 538,000,000USD | 601,000,000USD | 581,000,000USD | 443,000,000USD |
| Accumulated Other Comprehensive Income | 1,452,000,000USD | -2,978,000,000USD | -5,520,000,000USD | -6,429,000,000USD | 7,393,000,000USD | 8,934,000,000USD | 6,615,000,000USD | 2,151,000,000USD |
| Common Stock Shares Outstanding | 532,015,000shares | 565,015,000shares | 598,745,000shares | 637,655,000shares | 676,729,000shares | 716,192,000shares | 746,430,000shares | 774,650,000shares |
| Non Current Assets Total | 44,519,000,000USD | 110,558,000,000USD | 123,553,000,000USD | 96,418,000,000USD | 538,000,000USD | 132,230,000,000USD | 55,782,000,000USD | 114,643,000,000USD |
| Non Current Liabilities Total | 81,173,000,000USD | 91,468,000,000USD | 104,739,000,000USD | 91,962,000,000USD | 7,956,000,000USD | 7,899,000,000USD | 123,809,000,000USD | 116,944,000,000USD |
| Non Currrent Assets Other | 1,772,000,000USD | -91,439,000,000USD | -92,642,000,000USD | -14,066,000,000USD | -142,977,905,794USD | -18,920,000,000USD | 146,463,000,000USD | -114,643,000,000USD |
| Unclassified Non Current Assets | -48,026,000,000USD | -98,447,000,000USD | -105,210,000,000USD | 6,474,000,000USD | -282,396,000,000USD | -23,200,000,000USD | -102,162,000,000USD | 103,552,000,000USD |
| Unclassified Current Liabilities | 1,368,000,000USD | 449,000,000USD | 2,158,000,000USD | -1,296,000,000USD | -8,678,000,000USD | -4,661,000,000USD | — | -116,957,000,000USD |
| Unclassified Non Current Liabilities | 72,764,000,000USD | 84,066,000,000USD | 97,499,000,000USD | -107,108,000,000USD | -228,210,000,000USD | -242,595,000,000USD | -96,649,000,000USD | -92,000,000,000USD |
| Unclassified Equity | -26,916,000,000USD | -23,473,000,000USD | -20,760,000,000USD | 2,506,000,000USD | 2,394,000,000USD | 125,903,000,000USD | 2,178,000,000USD | 2,042,000,000USD |
| Other Assets | — | 117,566,000,000USD | 126,724,000,000USD | -45,011,000,000USD | 157,542,000,000USD | -78,963,000,000USD | -66,948,000,000USD | -62,320,000,000USD |
| Unclassified Current Assets | — | -68,256,000,000USD | -49,373,000,000USD | -7,229,000,000USD | -4,490,000,000USD | -7,842,000,000USD | -7,378,000,000USD | — |
| Inventory | — | — | -78,444,000,000USD | -7,229,000,000USD | -7,496,000,000USD | -7,842,000,000USD | -7,378,000,000USD | -7,004,000,000USD |
| Other Liab | — | — | — | 91,714,000,000USD | 116,333,000,000USD | 123,628,000,000USD | 102,180,000,000USD | 96,033,000,000USD |
| Accounts Payable | — | — | — | 1,296,000,000USD | 4,339,000,000USD | 4,661,000,000USD | 5,370,000,000USD | 4,020,000,000USD |
| Treasury Stock | — | — | — | -20,574,000,000USD | -18,185,000,000USD | -15,904,000,000USD | -14,395,000,000USD | -12,789,000,000USD |
| Non Current Liabilities Other | — | — | — | 99,914,000,000USD | 111,994,000,000USD | 118,967,000,000USD | 111,870,000,000USD | 107,146,000,000USD |
| Net Tangible Assets | — | — | — | 22,365,000,000USD | 33,253,000,000USD | 33,559,000,000USD | 28,959,000,000USD | 23,462,000,000USD |
| Property Plant Equipment Gross | — | — | — | — | — | 601,000,000USD | 581,000,000USD | 443,000,000USD |
| Short Long Term Debt | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Net Income | 1,844,000,000USD |
| Unclassified Operating Cash Flow | -764,000,000USD |
| Operating Cash Flow | 1,080,000,000USD |
| Other Investing Activities | 193,000,000USD |
| Unclassified Investing Cash Flow | 842,000,000USD |
| Investing Cash Flow | 1,035,000,000USD |
| Net Debt Issuance | 511,000,000USD |
| Net Common Stock Issuance | -1,977,000,000USD |
| Common Dividends Paid | -603,000,000USD |
| Other Financing Activities | 3,000,000USD |
| Unclassified Financing Cash Flow | -138,000,000USD |
| Financing Cash Flow | -2,204,000,000USD |
| Effect Of Forex Changes On Cash | -36,000,000USD |
| Change In Cash | -125,000,000USD |
| End Cash Flow | 6,120,000,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 1,019,000,000USD | 1,379,000,000USD | 1,639,000,000USD | 599,000,000USD | 29,000,000USD | 1,902,000,000USD | -93,000,000USD | 1,755,000,000USD |
| Other Non Cash Items | -164,000,000USD | 831,000,000USD | -1,559,000,000USD | 254,000,000USD | 616,000,000USD | -1,220,000,000USD | 1,413,000,000USD | -973,000,000USD |
| Change To Account Receivables | -30,000,000USD | -85,000,000USD | 48,000,000USD | -11,000,000USD | -37,000,000USD | 23,000,000USD | 9,000,000USD | -13,000,000USD |
| Change In Working Capital | 113,000,000USD | -566,000,000USD | 510,000,000USD | -454,000,000USD | -56,000,000USD | -349,000,000USD | -50,000,000USD | -527,000,000USD |
| Total Cash From Operating Activities | 968,000,000USD | 315,000,000USD | 1,252,000,000USD | 399,000,000USD | 589,000,000USD | 333,000,000USD | 1,270,000,000USD | 255,000,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | 968,000,000USD | 315,000,000USD | 1,252,000,000USD | 399,000,000USD | 589,000,000USD | 333,000,000USD | 1,270,000,000USD | 255,000,000USD |
| Investments | -2,469,000,000USD | 1,317,000,000USD | 28,000,000USD | 1,533,000,000USD | -359,000,000USD | 1,517,000,000USD | -1,030,000,000USD | 2,067,000,000USD |
| Total Cashflows From Investing Activities | 244,000,000USD | 359,000,000USD | 28,000,000USD | 1,533,000,000USD | -359,000,000USD | 1,517,000,000USD | -1,030,000,000USD | 2,067,000,000USD |
| Net Borrowings | -400,000,000USD | 0USD | -84,000,000USD | 1,039,000,000USD | 0USD | 0USD | 0USD | — |
| Total Cash From Financing Activities | -1,762,000,000USD | -1,184,000,000USD | -1,462,000,000USD | -162,000,000USD | -1,261,000,000USD | -1,084,000,000USD | -826,000,000USD | -1,320,000,000USD |
| Dividends Paid | -304,000,000USD | -292,000,000USD | -299,000,000USD | -301,000,000USD | -306,000,000USD | -267,000,000USD | -270,000,000USD | -272,000,000USD |
| Sale Purchase Of Stock | -1,000,000,000USD | -801,000,000USD | -1,000,000,000USD | -829,000,000USD | -900,000,000USD | -750,000,000USD | -500,000,000USD | -800,000,000USD |
| Issuance Of Capital Stock | 4,000,000USD | 3,000,000USD | 3,000,000USD | -2,000,000USD | 4,000,000USD | -7,000,000USD | 9,000,000USD | 6,000,000USD |
| Change In Cash | -591,000,000USD | -523,000,000USD | -197,000,000USD | 1,734,000,000USD | -998,000,000USD | 617,000,000USD | -448,000,000USD | 962,000,000USD |
| Begin Period Cash Flow | 6,245,000,000USD | 6,768,000,000USD | 6,965,000,000USD | 5,231,000,000USD | 6,229,000,000USD | 5,612,000,000USD | 6,060,000,000USD | 5,098,000,000USD |
| End Period Cash Flow | 5,654,000,000USD | 6,245,000,000USD | 6,768,000,000USD | 6,965,000,000USD | 5,231,000,000USD | 6,229,000,000USD | 5,612,000,000USD | 6,060,000,000USD |
| Other Cashflows From Investing Activities | 1,449,000,000USD | 28,410,000,000USD | -12,127,000,000USD | 2,749,000,000USD | 1,014,000,000USD | -1,524,000,000USD | -647,000,000USD | 1,822,000,000USD |
| Other Cashflows From Financing Activities | -62,000,000USD | -94,000,000USD | -82,000,000USD | -69,000,000USD | -59,000,000USD | -60,000,000USD | -65,000,000USD | -60,000,000USD |
| Unclassified Investing Cash Flow | 1,264,000,000USD | -29,368,000,000USD | 12,127,000,000USD | -2,749,000,000USD | -1,014,000,000USD | 1,524,000,000USD | 647,000,000USD | -1,822,000,000USD |
| Depreciation | — | -1,308,000,000USD | 655,000,000USD | 437,000,000USD | — | — | 419,000,000USD | 4,000,000USD |
| Stock Based Compensation | — | -21,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD | — | — | — |
| Unclassified Operating Cash Flow | — | — | — | -444,000,000USD | -7,000,000USD | — | -419,000,000USD | -4,000,000USD |
| Unclassified Financing Cash Flow | — | — | — | -2,000,000USD | — | — | 9,000,000USD | -188,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 3,646,000,000USD | 5,443,000,000USD | 4,659,000,000USD | 4,325,000,000USD | 4,778,000,000USD | 3,304,000,000USD | 2,920,000,000USD | 4,604,000,000USD |
| Other Non Cash Items | 68,000,000USD | -2,092,000,000USD | 183,000,000USD | -440,000,000USD | 524,000,000USD | 323,000,000USD | 742,000,000USD | -35,000,000USD |
| Change To Account Receivables | -66,000,000USD | 51,000,000USD | -133,000,000USD | 72,000,000USD | 52,000,000USD | -32,000,000USD | -55,000,000USD | -91,000,000USD |
| Change In Working Capital | -1,159,000,000USD | -644,000,000USD | -1,652,000,000USD | 1,166,000,000USD | 656,000,000USD | 1,828,000,000USD | 2,352,000,000USD | 1,559,000,000USD |
| Total Cash From Operating Activities | 2,555,000,000USD | 2,707,000,000USD | 3,190,000,000USD | 5,051,000,000USD | 5,958,000,000USD | 5,455,000,000USD | 6,014,000,000USD | 6,128,000,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | 2,555,000,000USD | 2,707,000,000USD | 3,190,000,000USD | 5,051,000,000USD | 5,958,000,000USD | 5,455,000,000USD | 6,014,000,000USD | 6,128,000,000USD |
| Investments | -985,000,000USD | 2,781,000,000USD | 1,536,000,000USD | -1,125,000,000USD | -3,230,000,000USD | -2,698,000,000USD | -3,333,000,000USD | -3,345,000,000USD |
| Total Cashflows From Investing Activities | 1,561,000,000USD | 2,781,000,000USD | 817,000,000USD | -2,378,000,000USD | -4,619,000,000USD | -3,171,000,000USD | -3,582,000,000USD | -5,431,000,000USD |
| Net Borrowings | 955,000,000USD | 629,000,000USD | 204,000,000USD | 417,000,000USD | 1,184,000,000USD | 614,000,000USD | 439,000,000USD | -86,000,000USD |
| Total Cash From Financing Activities | -4,069,000,000USD | -3,486,000,000USD | -3,723,000,000USD | -2,739,000,000USD | -1,115,000,000USD | -1,713,000,000USD | -1,616,000,000USD | -2,065,000,000USD |
| Dividends Paid | -1,198,000,000USD | -1,087,000,000USD | -966,000,000USD | -855,000,000USD | -769,000,000USD | -771,000,000USD | -793,000,000USD | -661,000,000USD |
| Sale Purchase Of Stock | -3,530,000,000USD | -2,800,000,000USD | -2,801,000,000USD | -2,301,000,000USD | -1,537,000,000USD | -1,627,000,000USD | -1,301,000,000USD | -1,351,000,000USD |
| Issuance Of Capital Stock | 8,000,000USD | 14,000,000USD | 11,000,000USD | 26,000,000USD | 34,000,000USD | 49,000,000USD | 58,000,000USD | — |
| Change In Cash | 16,000,000USD | 1,923,000,000USD | 363,000,000USD | -90,000,000USD | 245,000,000USD | 559,000,000USD | 846,000,000USD | -1,368,000,000USD |
| Begin Period Cash Flow | 6,229,000,000USD | 4,306,000,000USD | 3,943,000,000USD | 5,141,000,000USD | 4,896,000,000USD | 4,337,000,000USD | 3,491,000,000USD | 4,859,000,000USD |
| End Period Cash Flow | 6,245,000,000USD | 6,229,000,000USD | 4,306,000,000USD | 5,051,000,000USD | 5,141,000,000USD | 4,896,000,000USD | 4,337,000,000USD | 3,491,000,000USD |
| Other Cashflows From Investing Activities | 1,863,000,000USD | 1,900,000,000USD | 95,000,000USD | -1,253,000,000USD | -1,389,000,000USD | -473,000,000USD | -3,388,000,000USD | -2,085,000,000USD |
| Other Cashflows From Financing Activities | -304,000,000USD | -242,000,000USD | -177,000,000USD | 1,091,000,000USD | 1,507,000,000USD | 1,251,000,000USD | -50,000,000USD | 35,000,000USD |
| Unclassified Investing Cash Flow | 683,000,000USD | -1,900,000,000USD | -814,000,000USD | — | — | — | 3,139,000,000USD | — |
| Depreciation | — | — | 39,000,000USD | 1,170,000,000USD | 1,214,000,000USD | 1,282,000,000USD | 1,245,000,000USD | 1,132,000,000USD |
| Stock Based Compensation | — | — | 79,000,000USD | 65,000,000USD | 61,000,000USD | 59,000,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | -118,000,000USD | -1,235,000,000USD | -1,275,000,000USD | -1,341,000,000USD | -1,245,000,000USD | -1,132,000,000USD |
| Change To Liabilities | — | — | — | 1,094,000,000USD | 604,000,000USD | 1,860,000,000USD | 2,407,000,000USD | 1,650,000,000USD |
| Exchange Rate Changes | — | — | — | -24,000,000USD | 21,000,000USD | -12,000,000USD | 30,000,000USD | — |
| Cash And Cash Equivalents Changes | — | — | — | -90,000,000USD | 245,000,000USD | 559,000,000USD | 846,000,000USD | -1,368,000,000USD |
| Unclassified Financing Cash Flow | — | — | — | -1,091,000,000USD | -1,500,000,000USD | -1,180,000,000USD | 89,000,000USD | — |
| Change To Inventory | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
Aflac Japan Adjusted Expense Ratio
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 20.2 | percent | Disclosure |
Aflac Japan Annualized Premiums in Force
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 1,160,000,000,000 | JPY | Disclosure |
Aflac Japan Bank Distribution Partners
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 356 | banks | Disclosure |
Aflac Japan Bank Distribution Penetration
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 90 | percent | Disclosure |
Aflac Japan Benefit Ratio
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 64 | percent | Disclosure |
Aflac Japan Cancer Policies in Force
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 14,000,000 | policies | Disclosure |
Aflac Japan Individual Policies in Force
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 22,000,000 | policies | Disclosure |
Aflac Japan Licensed Sales Associates
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 111,000 | licensed sales associates | Disclosure |
Aflac Japan New Annualized Premium Sales
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 19,600,000,000 | JPY | Disclosure |
Aflac Japan New Money Yield
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 4.19 | percent | Disclosure |
Aflac Japan New Sales Agencies Recruited
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 139 | agencies | Disclosure |
Aflac Japan New Sales Mix: Affiliated Agencies
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 47.3 | percent | Disclosure |
Aflac Japan New Sales Mix: Banks
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 2.7 | percent | Disclosure |
Aflac Japan New Sales Mix: Cancer
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 55.2 | percent | Disclosure |
Aflac Japan New Sales Mix: Independent Agencies
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 50 | percent | Disclosure |
Aflac Japan New Sales Mix: Medical and Other Health
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 17.8 | percent | Disclosure |
Aflac Japan New Sales Mix: Ordinary Life
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 3.8 | percent | Disclosure |
Aflac Japan New Sales Mix: Other
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 0.7 | percent | Disclosure |
Aflac Japan New Sales Mix: Tsumitasu
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 22 | percent | Disclosure |
Aflac Japan New Sales Mix: WAYS
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 0.5 | percent | Disclosure |
Aflac Japan Portfolio Book Yield
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 3.39 | percent | Disclosure |
Aflac Japan Premium Persistency
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | ttm | 92.7 | percent | Disclosure |
Aflac Japan Pretax Adjusted Profit Margin
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 34.3 | percent | Disclosure |
Aflac Japan Return on Average Invested Assets
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 3.18 | percent | Disclosure |
Aflac Japan Sales Agencies
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 6,200 | agencies | Disclosure |
Aflac U.S. Adjusted Expense Ratio
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 36.1 | percent | Disclosure |
Aflac U.S. Annualized Premiums in Force
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 6,800,000,000 | USD | Disclosure |
Aflac U.S. Average Weekly Producers
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 5,100 | active producers | Disclosure |
Aflac U.S. Benefit Ratio
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 49.5 | percent | Disclosure |
Aflac U.S. New Annualized Premium Sales
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 349,000,000 | USD | Disclosure |
Aflac U.S. New Money Yield
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 6.37 | percent | Disclosure |
Aflac U.S. New Sales Mix: Accident
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 18.2 | percent | Disclosure |
Aflac U.S. New Sales Mix: Critical Care
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 17.2 | percent | Disclosure |
Aflac U.S. New Sales Mix: Dental/Vision
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 7.5 | percent | Disclosure |
Aflac U.S. New Sales Mix: Disability
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 26.3 | percent | Disclosure |
Aflac U.S. New Sales Mix: Hospital Indemnity
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 11.8 | percent | Disclosure |
Aflac U.S. New Sales Mix: Life
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 19 | percent | Disclosure |
Aflac U.S. Portfolio Book Yield
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 5.51 | percent | Disclosure |
Aflac U.S. Premium Persistency
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | ttm | 79.4 | percent | Disclosure |
Aflac U.S. Pretax Adjusted Profit Margin
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 20.9 | percent | Disclosure |
Aflac U.S. Return on Average Invested Assets
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 4.98 | percent | Disclosure |
Commercial Mortgage Loans Weighted-Average DSCR
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 2.59 | ratio | Disclosure |
Loans 90 Days or More Past Due
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 732,000,000 | USD | Disclosure |
Loans on Nonaccrual Status
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 797,000,000 | USD | Disclosure |
Total Past-Due Loans
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 895,000,000 | USD | Disclosure |
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Segment | Aflac Japan | 2,172,000,000 | USD | 0001628280-26-030923 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Aflac US | 1,779,000,000 | USD | 0001628280-26-030923 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Corporate And Other | 292,000,000 | USD | 0001628280-26-030923 |
| Q4 2025Quarterly · 2025-12-31 | Segment | Aflac Japan | 2,278,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Aflac US | 1,726,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Corporate And Other | 272,000,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Segment | Aflac Japan | 9,357,000,000 | USD | 0001628280-26-011402 |
| FY 2025Yearly · 2025-12-31 | Segment | Aflac US | 6,903,000,000 | USD | 0001628280-26-011402 |
| FY 2025Yearly · 2025-12-31 | Segment | Corporate And Other | 1,277,000,000 | USD | 0001628280-26-011402 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Aflac Japan | 2,335,000,000 | USD | 0001628280-25-049279 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Aflac US | 1,728,000,000 | USD | 0001628280-25-049279 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Corporate And Other | 343,000,000 | USD | 0001628280-25-049279 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Aflac Japan | 2,472,000,000 | USD | 0000004977-25-000132 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Aflac US | 1,728,000,000 | USD | 0000004977-25-000132 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Corporate And Other | 336,000,000 | USD | 0000004977-25-000132 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Aflac Japan | 2,272,000,000 | USD | 0001628280-26-030923 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Aflac US | 1,721,000,000 | USD | 0001628280-26-030923 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Corporate And Other | 326,000,000 | USD | 0001628280-26-030923 |
| Q4 2024Quarterly · 2024-12-31 | Segment | Aflac Japan | 2,361,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Aflac US | 1,672,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Corporate And Other | 286,000,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Segment | Aflac Japan | 9,659,000,000 | USD | 0001628280-26-011402 |
| FY 2024Yearly · 2024-12-31 | Segment | Aflac US | 6,739,000,000 | USD | 0001628280-26-011402 |
| FY 2024Yearly · 2024-12-31 | Segment | Corporate And Other | 1,007,000,000 | USD | 0001628280-26-011402 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Aflac Japan | 2,378,000,000 | USD | 0001628280-25-049279 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Aflac US | 1,684,000,000 | USD | 0001628280-25-049279 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Corporate And Other | 225,000,000 | USD | 0001628280-25-049279 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Aflac Japan | 2,447,000,000 | USD | 0000004977-25-000132 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Aflac US | 1,684,000,000 | USD | 0000004977-25-000132 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Corporate And Other | 249,000,000 | USD | 0000004977-25-000132 |
| FY 2023Yearly · 2023-12-31 | Segment | Aflac Japan | 10,664,000,000 | USD | 0001628280-26-011402 |
| FY 2023Yearly · 2023-12-31 | Segment | Aflac US | 6,623,000,000 | USD | 0001628280-26-011402 |
| FY 2023Yearly · 2023-12-31 | Segment | Corporate And Other | 460,000,000 | USD | 0001628280-26-011402 |
| FY 2022Yearly · 2022-12-31 | Segment | Aflac Japan | 11,890,000,000 | USD | 0000004977-25-000047 |
| FY 2022Yearly · 2022-12-31 | Segment | Aflac US | 6,486,000,000 | USD | 0000004977-25-000047 |
| FY 2022Yearly · 2022-12-31 | Segment | Corporate And Other | 267,000,000 | USD | 0000004977-25-000047 |
| FY 2021Yearly · 2021-12-31 | Segment | Aflac Japan | 14,373,000,000 | USD | 0000004977-24-000053 |
| FY 2021Yearly · 2021-12-31 | Segment | Aflac US | 6,489,000,000 | USD | 0000004977-24-000053 |
| FY 2021Yearly · 2021-12-31 | Segment | Corporate And Other | 175,000,000 | USD | 0000004977-24-000053 |
| FY 2020Yearly · 2020-12-31 | Segment | Aflac Japan | 15,371,000,000 | USD | 0000004977-23-000055 |
| FY 2020Yearly · 2020-12-31 | Segment | Aflac US | 6,565,000,000 | USD | 0000004977-23-000055 |
| FY 2020Yearly · 2020-12-31 | Segment | Corporate And Other | 384,000,000 | USD | 0000004977-23-000055 |
| FY 2019Yearly · 2019-12-31 | Segment | Aflac Japan | 15,313,000,000 | USD | 0000004977-22-000058 |
| FY 2019Yearly · 2019-12-31 | Segment | Aflac US | 6,550,000,000 | USD | 0000004977-22-000058 |
| FY 2019Yearly · 2019-12-31 | Segment | All Other Segments | 444,000,000 | USD | 0000004977-22-000058 |
| FY 2017Yearly · 2017-12-31 | Segment | All Other Segments | 140,000,000 | USD | 0000004977-18-000054 |
| FY 2017Yearly · 2017-12-31 | Segment | Corporate And Eliminations | 210,000,000 | USD | 0000004977-18-000054 |
| FY 2017Yearly · 2017-12-31 | Segment | Operating Segments — Aflac Japan | 15,028,000,000 | USD | 0000004977-18-000054 |
| FY 2017Yearly · 2017-12-31 | Segment | Operating Segments — Aflac Us | 6,289,000,000 | USD | 0000004977-18-000054 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.